Detalles de la búsqueda
1.
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC.
Int J Mol Sci
; 24(17)2023 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685884
2.
Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
Exp Mol Pathol
; 99(3): 485-91, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26407762
3.
Functional Proteomic Profiling of Triple-Negative Breast Cancer.
Cells
; 10(10)2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34685748
4.
Proteomic profiling of human colon cancer cells treated with the histone deacetylase inhibitor belinostat.
Electrophoresis
; 31(16): 2714-21, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20717991
5.
Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
Toxicology
; 255(1-2): 72-9, 2009 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19010377
6.
Biomarkers in tumors of the central nervous system - a review.
APMIS
; 127(5): 265-287, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30740783
7.
Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance.
Cancers (Basel)
; 11(7)2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31266248
8.
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
Mol Cancer
; 7: 70, 2008 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18789133
9.
Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment.
Oncotarget
; 9(40): 26195-26208, 2018 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29899852
10.
The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA.
Cancer Cytopathol
; 126(4): 275-281, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29266837
11.
Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.
Cancer Res
; 65(16): 7470-7, 2005 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16103101
12.
Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment.
Acta Ophthalmol
; 95(3): 299-306, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27808478
13.
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.
Lung Cancer
; 113: 14-17, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29110841
14.
The interleukin-6/Janus kinase/STAT3 pathway in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the lacrimal gland.
Acta Ophthalmol
; 94(8): 798-804, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27286739
15.
Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
PLoS One
; 11(9): e0163444, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27685259
16.
Medullary carcinoma of the colon: can the undifferentiated be differentiated?
Virchows Arch
; 466(1): 13-20, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25339302
17.
Activation of the interleukin-6/Janus kinase/STAT3 pathway in pleomorphic adenoma of the parotid gland.
APMIS
; 123(8): 706-15, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26061266
18.
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
Anticancer Res
; 35(11): 6223-9, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26504055
19.
Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
BMC Pharmacol
; 4: 31, 2004 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-15575955